Odyssey Therapeutics
Boston, United States· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Total funding raised: $482M
Overview
A biotech firm developing innovative oncology and immunology therapies using an integrated platform of biologics and small molecules.
OncologyImmunology
Technology Platform
An integrated discovery platform combining structural biology, computational design, and diverse therapeutic modalities to create targeted drugs.
Funding History
3Total raised:$482M
PIPE$213M
Venture$101M
PIPE$168M
Opportunities
Potential for breakthrough efficacy in combination regimens or in patient subsets unresponsive to current standards of care.
Risk Factors
High clinical development risk and intense competition could limit commercial success even with positive data.
Competitive Landscape
Competes with numerous biotechs and large pharma in the crowded immuno-oncology space, requiring clear mechanistic differentiation.